Phuong N. Huynh

Array ( [id] => 6705817 [patent_doc_number] => 20030152551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => '2-Methyl-3-butenyl-1-pyrophosphoric acid salt and agent for treating lymphocytes' [patent_app_type] => new [patent_app_number] => 10/372214 [patent_app_country] => US [patent_app_date] => 2003-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4749 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20030152551.pdf [firstpage_image] =>[orig_patent_app_number] => 10372214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 709612 [patent_doc_number] => 07056509 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-06 [patent_title] => 'Antibody methods for selectively inhibiting VEGF' [patent_app_type] => utility [patent_app_number] => 10/373561 [patent_app_country] => US [patent_app_date] => 2003-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 87859 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/056/07056509.pdf [firstpage_image] =>[orig_patent_app_number] => 10373561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 382830 [patent_doc_number] => 07306782 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-11 [patent_title] => 'Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases' [patent_app_type] => utility [patent_app_number] => 10/366569 [patent_app_country] => US [patent_app_date] => 2003-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 4886 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/306/07306782.pdf [firstpage_image] =>[orig_patent_app_number] => 10366569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7239495 [patent_doc_number] => 20050080237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-14 [patent_title] => 'Oligomeric molecules and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/504400 [patent_app_country] => US [patent_app_date] => 2003-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4558 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0080/20050080237.pdf [firstpage_image] =>[orig_patent_app_number] => 10504400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6804661 [patent_doc_number] => 20030232055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-18 [patent_title] => 'Innate immune system-directed vaccines' [patent_app_type] => new [patent_app_number] => 10/353316 [patent_app_country] => US [patent_app_date] => 2003-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 24430 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20030232055.pdf [firstpage_image] =>[orig_patent_app_number] => 10353316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7383046 [patent_doc_number] => 20040029268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Endothelialization of vascular surfaces' [patent_app_type] => new [patent_app_number] => 10/353384 [patent_app_country] => US [patent_app_date] => 2003-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9098 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20040029268.pdf [firstpage_image] =>[orig_patent_app_number] => 10353384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 494586 [patent_doc_number] => 07211649 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-05-01 [patent_title] => 'Cartilage intermediate layer protein' [patent_app_type] => utility [patent_app_number] => 10/349188 [patent_app_country] => US [patent_app_date] => 2003-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 20 [patent_no_of_words] => 14404 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/211/07211649.pdf [firstpage_image] =>[orig_patent_app_number] => 10349188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847706 [patent_doc_number] => 20030166873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'VEGF-related protein' [patent_app_type] => new [patent_app_number] => 10/346802 [patent_app_country] => US [patent_app_date] => 2003-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 26100 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166873.pdf [firstpage_image] =>[orig_patent_app_number] => 10346802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6797470 [patent_doc_number] => 20030176344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Human osteoporosis gene' [patent_app_type] => new [patent_app_number] => 10/346723 [patent_app_country] => US [patent_app_date] => 2003-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25928 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20030176344.pdf [firstpage_image] =>[orig_patent_app_number] => 10346723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7116248 [patent_doc_number] => 20050069549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'Targeted ligands' [patent_app_type] => utility [patent_app_number] => 10/501453 [patent_app_country] => US [patent_app_date] => 2003-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 91855 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20050069549.pdf [firstpage_image] =>[orig_patent_app_number] => 10501453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6842558 [patent_doc_number] => 20030147905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Therapeutic compounds' [patent_app_type] => new [patent_app_number] => 10/338730 [patent_app_country] => US [patent_app_date] => 2003-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16738 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20030147905.pdf [firstpage_image] =>[orig_patent_app_number] => 10338730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7394022 [patent_doc_number] => 20040038339 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex' [patent_app_type] => new [patent_app_number] => 10/239656 [patent_app_country] => US [patent_app_date] => 2003-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 19641 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038339.pdf [firstpage_image] =>[orig_patent_app_number] => 10239656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6978769 [patent_doc_number] => 20050288487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Human mast cell-expressed membrane proteins' [patent_app_type] => utility [patent_app_number] => 10/500784 [patent_app_country] => US [patent_app_date] => 2003-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14753 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20050288487.pdf [firstpage_image] =>[orig_patent_app_number] => 10500784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5520878 [patent_doc_number] => 20090028859 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'Bispecific antibodies that bind to vegf receptors' [patent_app_type] => utility [patent_app_number] => 10/520026 [patent_app_country] => US [patent_app_date] => 2002-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13558 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20090028859.pdf [firstpage_image] =>[orig_patent_app_number] => 10520026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7467993 [patent_doc_number] => 20040120950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Modulation of VEGF-C/VEGFR-3 interactions in the treatment of rheumatoid arthritis' [patent_app_type] => new [patent_app_number] => 10/326048 [patent_app_country] => US [patent_app_date] => 2002-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17702 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20040120950.pdf [firstpage_image] =>[orig_patent_app_number] => 10326048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6796413 [patent_doc_number] => 20030175287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Innate immune system-directed vaccines' [patent_app_type] => new [patent_app_number] => 10/319854 [patent_app_country] => US [patent_app_date] => 2002-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 24730 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175287.pdf [firstpage_image] =>[orig_patent_app_number] => 10319854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6710426 [patent_doc_number] => 20030170175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Cytotoxic therapy' [patent_app_type] => new [patent_app_number] => 10/318366 [patent_app_country] => US [patent_app_date] => 2002-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26445 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20030170175.pdf [firstpage_image] =>[orig_patent_app_number] => 10318366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6710426 [patent_doc_number] => 20030170175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Cytotoxic therapy' [patent_app_type] => new [patent_app_number] => 10/318366 [patent_app_country] => US [patent_app_date] => 2002-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26445 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20030170175.pdf [firstpage_image] =>[orig_patent_app_number] => 10318366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6642446 [patent_doc_number] => 20030103966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Method to induce the Th1 immune response' [patent_app_type] => new [patent_app_number] => 10/310304 [patent_app_country] => US [patent_app_date] => 2002-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7357 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20030103966.pdf [firstpage_image] =>[orig_patent_app_number] => 10310304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6682793 [patent_doc_number] => 20030118657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Treatment of disease states characterized by excessive or inappropriate angiogenesis' [patent_app_type] => new [patent_app_number] => 10/308512 [patent_app_country] => US [patent_app_date] => 2002-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7229 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20030118657.pdf [firstpage_image] =>[orig_patent_app_number] => 10308512 [rel_patent_id] =>[rel_patent_doc_number] =>)